4.3 Article

Value of reflectance confocal microscopy for the monitoring of rosacea during treatment with topical ivermectin

Journal

JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 33, Issue 1, Pages 195-203

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09546634.2020.1741501

Keywords

Reflectance confocal microscopy; rosacea; Demodex; inflammation; ivermectin

Categories

Funding

  1. Galderma

Ask authors/readers for more resources

This study evaluated the value of reflectance confocal microscopy (RCM) in monitoring Demodex mites, inflammation, and vascular parameters in rosacea during treatment. The results showed that treatment reduced inflammatory lesions and the number of mites, but had no significant impact on inflammatory cells, epidermal thickness, or vascular parameters. The study concludes that RCM, in its current form, has limited value for noninvasive follow-up of rosacea in clinical practice due to device limitations.
Background: Reflectance confocal microscopy (RCM) enables noninvasive Demodex mite detection in rosacea. Objective scoring of rosacea severity is currently lacking. Objectives: To determine the value of RCM for monitoring Demodex, inflammation and vascular parameters in rosacea during treatment. Methods: In 20 rosacea patients, clinical and RCM examination were performed before, during, and 12 weeks after a 16-week treatment course with topical ivermectin. Using RCM, number of mites and inflammatory cells, epidermal thickness, and vascular density and diameter were measured. RCM features were correlated with clinical assessment. Results: Treatment resulted in clinical reduction of inflammatory lesions. Mites were detected in 80% of patients at baseline, 30% at week 16, and 63% at week 28. The number of mites reduced significantly during treatment, but no changes in inflammatory cells, epidermal thickness or vascular parameters were observed. Correlation between number of inflammatory lesions and mites was low. None of the RCM variables were significant predictors for clinical success. Conclusions: RCM enables anti-inflammatory effect monitoring of topical ivermectin by determining mite presence. Quantifying exact mite number, and inflammatory and vascular characteristics is challenging due to device limitations. In its current form, RCM seems of limited value for noninvasive follow-up of rosacea in clinical practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available